Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant 2007 Jul;40(2):181

Date

05/16/2007

Pubmed ID

17502895

DOI

10.1038/sj.bmt.1705707

Scopus ID

2-s2.0-34447284249 (requires institutional sign-in at Scopus site)   7 Citations

Author List

Michaelis L, Lin S, Joseph L, Artz AS, Kline J, Pollyea D, Stock W, Rich E, Collins-Jones D, Casey B, Del Cerro P, van Besien K

Author

Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Graft vs Host Disease
Hematologic Neoplasms
Humans
Stem Cell Transplantation
Transplantation Chimera
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome